Generic Medicine Info
May be taken with or without food.
Concomitant use w/ aliskiren in patients w/ diabetes and renal impairment (GFR <60 mL/min). Pregnancy.
Special Precautions
Patients w/ CHF, volume depletion, unstented unilateral or bilateral renal artery stenosis, significant aortic or mitral stenosis. Hepatic and renal impairment. Lactation. Monitoring Parameters Monitor BP, electrolytes, serum creatinine, BUN, K levels.
Adverse Reactions
Fatigue, depression, hypertriglyceridaemia, abdominal pain, nausea, diarrhoea, vomiting, UTI, upper resp tract infection, rhinitis, pharyngitis, cough, viral infection, injury, dizziness, headache, arthralgia, back pain, rash, pruritus.
Drug Interactions
May increase serum lithium levels and toxicity. Additive hyperkalaemic effect when used w/ K-sparing diuretics, K supplements or K-containing salt substitutes. NSAIDs may attenuate antihypertensive effect and result in deterioration of renal function including possible acute renal failure.
ATC Classification
C09CA02 - eprosartan ; Belongs to the class of angiotensin II antagonists. Used in the treatment of cardiovascular disease.
Disclaimer: This information is independently developed by CIMS based on eprosartan from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in